Obesity

Weight Management Weight Loss Treatment Options Weight Loss Treatments Health Risks Causes Treatment Medications Diabetes Childhood Obesity

Eli Lilly Becomes First Health Care Company Valued at $1 Trillion

Soaring GLP‑1 sales, plus expectations for an oral obesity pill, lifted the drugmaker to the milestone.

Brain Maps of GLP-1 Drugs Point to Paths for Weight Loss Without Nausea

Brain Implants Show Mounjaro Temporarily Quiets Food-Craving Brain Signal

Childhood Hypertension Nearly Doubled Worldwide, Lancet Study Finds

OECD Flags High Alcohol Use in Germany and Austria in 2025 Health Snapshot

GLP-1 Drugs Linked to Lower Five-Year Death Risk in Colon Cancer, UCSD Study Finds

White House Finalizes GLP-1 Price Deal With Lilly and Novo, Setting $50 Medicare Copays

Pfizer Wins Metsera With $10 Billion Cash‑Plus‑CVR Offer as Novo Withdraws

Pfizer Wins Early U.S. Antitrust Clearance for Metsera Deal as Novo’s Higher Bid Pressures Timeline

Lilly Taps Walmart for First Retail Pickup of Discounted Zepbound Vials Starting Mid-November

SELECT Analysis Finds Semaglutide Protects the Heart Beyond Weight Loss

Michael McIntyre Reveals He Is Using Mounjaro After Obesity Diagnosis

Lancet Analysis: Semaglutide Cuts Major Heart Events Regardless of Weight Loss

Lilly Taps Cipla to Market Tirzepatide as ‘Yurpeak’ in India at Mounjaro Price Parity

Viking Therapeutics Jumps After Wider Q3 Loss as R&D Ramp Signals Obesity-Drug Progress

Ventyx’s NLRP3 Drug Cuts Inflammation Markers in Phase 2, Shares Soar

Coventry Mum Halves Body Weight, Says She Now Sees 'Thin Privilege'

Large UK Brain Study Links Ultra-Processed Food Intake to Changes in Hunger and Reward Circuits

Mediterranean and Other Anti-Inflammatory Diets Linked to Better Sexual Function and Fewer Incontinence Symptoms, Meta-Analysis Finds

Wegovy Launches in Argentina With Adolescent Indication and Proven Cardiovascular Benefit